Drugs Information:
Enoxaparin
Basic Information
|
||
| ID | DDInter645 | |
| Drug Type | small molecule | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| CAS Number | 9005-49-6 | |
| Description | Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.[L31393] Enoxaparin markedly reduces the incidence of venous thromboembolism in hospitalized patients when compared to unfractionated [heparin], without increasing the risk of serious bleeding.[A228178,A228313] | |
| ATC Classification | B01AB05 | |
| IUPAC Name | None | |
| InChI | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank PubChem Substance KEGG Drug ChemSpider PharmGKB Therapeutic Targets Database Wikipedia ChEMBL | |
Interactions with
Enoxaparin
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|